In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer is a research paper published in Cell (2021). On theSindex it has a DataRank of 0.809. It has been cited 219 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.809
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Parker Institute for Cancer Immunotherapy
Grant: 1111469
National Institutes of Health
Grant: HG010480
National Institutes of Health
Grant: AI117950
National Institutes of Health
Grant: MH109905
National Institutes of Health
Grant: AI108545
National Institutes of Health
Grant: AI149680
National Institutes of Health
Grant: AI082630
National Institutes of Health
Grant: AI105343
National Institutes of Health
Grant: AI115712
National Institutes of Health
Grant: AI112521
National Institutes of Health
Grant: CA210944
National Institutes of Health
Grant: CA234842
NIAID NIH HHS
Grant: R01 AI105343
NHGRI NIH HHS
Grant: R01 HG010480
NIAID NIH HHS
Grant: U19 AI149680
NCI NIH HHS
Grant: F99 CA234842
NIAID NIH HHS
Grant: U19 AI082630
NCI NIH HHS
Grant: P01 CA210944
NIA NIH HHS
Grant: P30 AG073104
NCI NIH HHS
Grant: T32 CA009140
NIAID NIH HHS
Grant: U19 AI117950
NIAID NIH HHS
Grant: R01 AI115712
NIAID NIH HHS
Grant: P01 AI112521
NCI NIH HHS
Grant: K00 CA234842
NIAID NIH HHS
Grant: P01 AI108545
NIAID NIH HHS
Grant: R01 AI155577
NCI NIH HHS
Grant: R01 CA078831
NIMH NIH HHS
Grant: R01 MH109905
Searle Scholars Program
Stand up to Cancer
The Mark Foundation for Cancer Research
MeSH Terms
Keywords
Additional file 1 of The immunometabolite S-2-hydroxyglutarate exacerbates perioperative ischemic brain injury and cognitive dysfunction by enhancing CD8+ T lymphocyte-mediated neurotoxicity
Additional file 1 of The immunometabolite S-2-hydroxyglutarate exacerbates perioperative ischemic brain injury and cognitive dysfunction by enhancing CD8+ T lymphocyte-mediated neurotoxicity
Additional file 1 of Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma
Additional file 1 of Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma
Additional file 6 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 4 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 5 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 5 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 6 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 2 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 3 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 2 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 3 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 4 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 1 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer
Additional file 1 of Integrated analysis reveals FLI1 regulates the tumor immune microenvironment via its cell-type-specific expression and transcriptional regulation of distinct target genes of immune cells in breast cancer